Notably, the released Orz sensitized tumor cells toward anti-PD-L1 treatment through increasing their PD-L1 expression.Moreover, the AMPCP-mediated inhibition of CD73 decreased the levelof adenosine to overcome immunosuppressive TMME. Here, NT5E is linked to neoplasm.